1. Evaluation of pretreatment red cell distribution width in patients with multiple myeloma
   Jing Wang et al, 2017, Cancer Biomarkers CrossRef
2. Evaluation of neutrophil-to-lymphocyte ratio in newly diagnosed patients receiving borte- zomib-based therapy for multiple myeloma
   Xin Zhou et al, 2018, Cancer Biomarkers CrossRef
3. Bortezomib retreatment for relapsed and refractory multiple myeloma in real‐world clinical practice
   Cyrille Hulin et al, 2019, Health Science Reports CrossRef